辅修(学术)
生化工程
化学
生物技术
传统医学
计算生物学
生物
工程类
医学
政治学
法学
作者
Jia-Long Guo,Chang Liu,Yao Wang,Chengfu Yuan,Ding Yuan,Yumin He
出处
期刊:PubMed
日期:2024-01-01
卷期号:49 (2): 304-314
标识
DOI:10.19540/j.cnki.cjcmm.20230824.201
摘要
Minor ginsenosides are a class of processed saponins with minor natural content, high bioavailability, and outstanding bio-logical activity, which are usually obtained by biological or chemical transformation of prototype saponins directly extracted from Panax plants. In recent years, with the clarification of the biosynthetic pathway of saponins and the development of synthetic biology, it has become possible to use synthetic metabolic engineering methods with microorganisms as hosts to produce saponins. Minor ginsenosides have received widespread attention because of their remarkable biological activities in enhancing the immune function of the body and antitumor property. At present, most of the reviews on minor ginsenosides focus on transformation preparation, process optimization, and pharmacological activity, but there are some deficiencies in industrial analysis. This study summarized structural types, pharmacological activities, sources of acquisition, and transformation pathways of minor ginsenosides based on the relevant literature in China and abroad, proposed problems in the preparation of existing minor ginsenosides, and discussed the future research and utilization prospects, to provide a theoretical basis for improving the basic research of minor ginsenosides and promoting their industrialization.
科研通智能强力驱动
Strongly Powered by AbleSci AI